Involvement of α6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion

NeuroReport

Volumn 10, Issue 12, 1999, Pages 2497-2501

  Le Novère, Nicolas ^a   Zoli, Michele ^a,b   Léna, Clément ^a   Ferrari, Rosaria ^b   Picciotto, Marina R ^a,d   Merlo Pich, Emilio ^c   Cnangeux, Jean Pierre ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c GSK   (Italy)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Cholinergic behavior; Dopaminergic system

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; PEPTIDE FRAGMENT;

ANIMAL TISSUE; ARTICLE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EFFECT; HABITUATION; LOCOMOTION; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; INFUSION PUMP; MALE; MOLECULAR GENETICS; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; INFUSION PUMPS, IMPLANTABLE; LOCOMOTION; MALE; MESENCEPHALON; MOLECULAR SEQUENCE DATA; NEURONS; NICOTINE; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0033587809     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199908200-00012     Document Type: Article

References (25)

1. 1. Changeux JP, Bessis A, Bourgeois JP et al. Cold Spring Harbor Symp Quant Biol LXI, 343-362 (1996).
2. 2. Role LW and Berg DK. Neuron 16, 1077-1095 (1996).
3. 3. Stolerman I, Garcha H and Mirza N. Psychopharmacology 117, 430-437 (1995).
4. 4. Museo E and Wise RA. Pharmacol Biochem Behav 35, 735-737 (1990).
5. 5. Museo E and Wise RA. Pharmacol Biochem Behav 37, 113-116 (1990).
6. 6. Louis M and Clarke P. Neuropharmacology 38, 1503-1513 (1998).
7. 7. Le Novère N, Zoli M and Changeux JP. Eur J Neurosci 8, 2428-2439 (1996).
8. 8. Pidoplichko VI, DeBiasi M, Williams JT and Dani JA. Nature 390, 401404 (1997).
9. 9. Picciotto MR, Zoli M, Rimondini R et al. Nature 391, 173-177 (1998).
10. 10. Zoli M, Léna C, Picciotto MR and Changeur JP. J Neurosci 18, 4461-4472 (1998).
11. 11. Marubio L, Arroyo-Jimenez M, Cordero-Erausquin M et al. Nature 398, 805-810 (1999).
12. 12. Grady S, Marks M, Wonnacott S and Collins A. J Neurochem 59, 848-856 (1992).
13. 13. Schulz D and Zigmond R. Neurosci Lett 98, 310-316 (1989).
14. 14. Kulak J, Nguyen T, Olivera B and McIntosh J. J Neurosci 17, 5263-5270 (1997).
15. 15. Kaiser S, Soliakov L, Harvey S et al. J Neurochem 70, 1069-1076 (1998).
16. 16. Goldner FM, Dineley KT and Patrick JW. Neuroreport 8, 2738-2742 (1997).
17. 17. Elliott KJ, Jones JM, Sacaan AL et al. J Mol Neurosci 10, 251-260 (1998).
18. 18. Le Novère N and Changeux JP. J Mol Evol 40, 155-172 (1995).
19. 19. Bottenstein JE and Sato GH. Proc Natl Acad Sci USA 76, 514-517 (1979).
20. 20. Whitesell L, Geselowitz D, Chavany C et al. Proc Natl Acad Sci USA 90, 4665-4669 (1993).
21. 21. Wahlestedt C, Golanov E, Yamamoto S et al. Nature 363, 260-263 (1998).
22. 22. Luetje C, Wada K, Rogers B et al. J Neurochem 55, 632-640 (1990).
23. 23. Cartier GE, Yoshikami D, Gray WR et al. J Biol Chem 271, 7522-7528 (1998).
24. 24. Clarke P and Reuben M. Br J Pharmacol 117, 595-606 (1996).
25. 25. Wada E, Wada K, Boulter J et al. J Comp Neurol 284, 314-335 (1989).